{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T17:29:53Z","timestamp":1774200593357,"version":"3.50.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1K23AR082918"],"award-info":[{"award-number":["1K23AR082918"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1K23AR078930"],"award-info":[{"award-number":["1K23AR078930"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03208-5","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T10:44:21Z","timestamp":1720694661000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Limited English proficiency is associated with access barriers to isotretinoin for acne"],"prefix":"10.1007","volume":"316","author":[{"given":"James","family":"Choe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Charrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Mostaghimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Shiboski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aileen Y.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Barbieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"3208_CR1","doi-asserted-by":"crossref","unstructured":"Reynolds RV et al (2024) Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 0Guidelines of care for the management of acne vulgaris. Reynolds RV, Yeung H, Cheng CE, Cook-Bolden F, Desai SR, Druby KM, Freeman EE, Keri JE, Stein Gold LF, Tan JKL, Tollefson MM, Weiss JS, Wu PA, Zaenglein AL, Han JM, Barbieri JS. J Am Acad Dermatol. 2024 May;90(5):1006.e1-1006.e30. doi: 10.1016\/j.jaad.2023.12.017. Epub 2024 Jan 30. PMID: 38300170","DOI":"10.1016\/j.jaad.2023.12.017"},{"key":"3208_CR2","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1111\/j.1525-1497.2005.0174.x","volume":"20","author":"E Wilson","year":"2005","unstructured":"Wilson E, Chen AH, Grumbach K, Wang F, Fernandez A (2005) Effects of Limited English proficiency and Physician Language on Health Care Comprehension. J Gen Intern Med 20:800\u2013806","journal-title":"J Gen Intern Med"},{"issue":"3","key":"3208_CR3","doi-asserted-by":"publisher","first-page":"e0210445","DOI":"10.1371\/journal.pone.0210445","volume":"14","author":"A Charrow","year":"2019","unstructured":"Charrow A, Xia FD, Lu J, Waul M, Joyce C, Mostaghimi A (2019) Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era. PLoS ONE 14(3):e0210445","journal-title":"PLoS ONE"},{"key":"3208_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamadermatol.2019.3270","volume":"156","author":"JS Barbieri","year":"2020","unstructured":"Barbieri JS, Frieden IJ, Nagler AR, Isotretinoin (2020) Patient safety, and patient-centered care-time to Reform iPLEDGE. JAMA Dermatol 156:21\u201322","journal-title":"JAMA Dermatol"},{"issue":"24","key":"3208_CR5","doi-asserted-by":"publisher","first-page":"00133","DOI":"10.1016\/j.jaad.2024.01.033","volume":"S0190\u20139622","author":"S Ershadi","year":"2024","unstructured":"Ershadi S, Choe J, Barbieri JS (2024) Medicaid formularies for acne treatments are difficult to access and reflect inconsistent coverage policies. J Am Acad Dermatol S0190\u20139622(24):00133\u201300136. https:\/\/doi.org\/10.1016\/j.jaad.2024.01.033","journal-title":"J Am Acad Dermatol"}],"updated-by":[{"DOI":"10.1007\/s00403-024-03459-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000}}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03208-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03208-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T12:02:21Z","timestamp":1731153741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03208-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":5,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3208"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03208-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00403-024-03459-2","asserted-by":"object"}]},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"assertion":[{"value":"5 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00403-024-03459-2","URL":"https:\/\/doi.org\/10.1007\/s00403-024-03459-2","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Barbieri reported personal fees from Dexcel Pharma for consulting outside the submitted work. Dr. Mostaghimi has received consulting fees from Pfizer, hims, Digital Diagnostics, Concert, Lilly, and AbbVie as well as licensing\/royalties from Pfizer and Concert and holds equity in and is on the advisory board for hims and Fig.\u00a01. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"This study was approved by the Mass General Brigham (MGB) Institutional Review Board (2023P003578).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"IRB approval status"}},{"value":"John Barbieri.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reprint requests"}},{"value":"The National Institute of Arthritis and Musculoskeletal and Skin Diseases had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the funder\/sponsor"}}],"article-number":"464"}}